COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $924,882 | -62.8% | 216,600 | +27.3% | 0.00% | 0.0% |
| Q1 2021 | $2,486,000 | +35.3% | 170,168 | +61.0% | 0.00% | 0.0% |
| Q4 2020 | $1,837,000 | -5.3% | 105,715 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,939,000 | -9.6% | 105,715 | -12.0% | 0.00% | 0.0% |
| Q2 2020 | $2,146,000 | +574.8% | 120,139 | +511.1% | 0.00% | – |
| Q1 2020 | $318,000 | -39.4% | 19,660 | -32.5% | 0.00% | – |
| Q4 2019 | $525,000 | -11.3% | 29,113 | -0.5% | 0.00% | -100.0% |
| Q3 2019 | $592,000 | -85.1% | 29,250 | -84.6% | 0.00% | -75.0% |
| Q1 2017 | $3,975,000 | -13.2% | 189,745 | +16.7% | 0.00% | 0.0% |
| Q4 2016 | $4,577,000 | +22.3% | 162,605 | +14.3% | 0.00% | 0.0% |
| Q3 2016 | $3,741,000 | +379.0% | 142,305 | +207.6% | 0.00% | +300.0% |
| Q2 2016 | $781,000 | – | 46,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
| Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
| Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
| TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
| Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
| Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
| Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
| Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |